Image 3 caroussel

Scientific Program

 

Scientific program

 

Wednesday 17th November
13:45-14:00 Opening ceremony
14:00-16:00 Liquid biopsies
16:00-17:00 Poster session (1)
17:00-18:30    
Ions channels & Cancer   Translational research, from biology to the clinic   Health technologies
18:30-19:30 Icebreaker: Drinks & Posters
20:30-23:00 Speaker and moderator dinner, under invitation

 

Thursday 18th November
8:30-10:05 Myeloid cells in cancer
10:05-11:00 Poster session (2)
11:00-12:45 Preneoplasia & Early dissemination
12:45-14:15 Lunch
14:15-15:50    
Cell signaling and therapeutic targets   Genome dynamics and cancer   Patients-partenaire-formateur-co-chercheur : des savoirs expérientiels légitimes ?
15:45-16:45 Break
16:45-18:15 Research in melanoma  
Le patient-partenaire en institution
19:30 Gala dinner, social event

 

Friday 19th November
08:30-10:15    
Poor prognosis cancers: Brain tumors   Extracellular matrix & cancer   Le patient formateur
10:15-11:00 Break
11:00-12:30 Poor prognosis cancers: Pancreatic cancer  
Le patient co--chercheur
12:30-12:45 Poster Awards - Closing ceremony
12:45-14:00 Lunch

 

 

Wednesday 17th November

13:45 - 14:00 : Opening ceremony

Muriel MATHONNET, Scientific director of Cancéropôle Grand Sud-Ouest

 

14:00 - 16:00 : Plenary session

  • Liquid biopsies
    Chairs: 
    • KEYNOTE SPEAKER: Caroline DIVE, Cancer Research UK, Manchester (United Kingdom)
    • Sandrine DABERNAT, BMGIC (Bordeaux) - Extracellular vesicle liquid biopsy: the next generation cancer biomarker ?
    • 2 selected communications
    • KEYNOTE SPEAKER: Valérie TALY, Centre de Recherche des Cordeliers, Inserm U1138, CNRS SNC5096 (Paris) - Tracking circulating tumor DNA for cancer patient follow-up

 

17:00 - 18:30 : Parallel sessions organized by Cancéropôle GSO Axes

  • Ions channels & Cancer / Axis 1 session
    Chair: Nicolas BOURMEYSTER
    • KEYNOTE SPEAKER: Albrecht SCHWAB, Institut für Physiolgie II, Münster (Germany) - Ionic signaling in pancreatic ductal adenocarcinoma
    • Calcium signaling in cancer stem cells - Bruno CONSTANTIN, Laboratoire STIM - CNRS ERL 7003 - EA 7349 (Poitiers)
    • Manipulation of ionic channels and calcium signaling in glioblastoma with infrared radiation"1 selected communication - David MOREAU, École des Mines de Saint-Étienne
    • 1 invited speaker

 

  • Translational research, from biology to the clinic & Flash Posters / Axis 3 session
    Chair: Majid KHATIB
    • 8 selected communications

 

  • Health technologies / Axis 5 session
    Chair:
    • EMERGENCE CALLS
      • 2 invited speakers
    • 5 selected talks for "Ma techno en 180 secondes" (flash posters toutes technologies)

 

Thursday 18th November

08:30 - 10:05 : Plenary session

  • Myeloid cells in cancer 
    Chairs: Mary POUPOT & Nicolas LARMONIER
    • KEYNOTE SPEAKER: Antonio SICA, University of Piemonte Orientale 'A. Avogadro' (Novara) and Humanitas Clinical and Research Center, Milan (Italy) - Therapeutic targeting of myelopoiesis in cancer
    • Integrin signaling in tumor-associated macrophages - Frédéric LAGARRIGUE, Institute of Pharmacology and Structural Biology (Toulouse)
    • Lessons from the remote alteration of granulopoiesis in NSCLC: what is neutrophil homeostasis telling us on immune checkpoint blockade ? - Julien FAGET, Montpellier Cancer Research Institute (IRCM)
    • The tumor-promoting myeloid landscape in breast cancers - Céline BLAYE, Institut Bergonié and ImmunoConcept Lab (Bordeaux)

 

11:00 - 12:45 : Plenary session

  • Preneoplasia & early dissemination 
    Chairs: David SANTAMARIA
    • KEYNOTE SPEAKER: Daniel MUNOZ-ESPIN, University of Cambridge (United Kingdom) - Role of cellular senescence in lung precancerous lesions: senotherapeutic opportunities
    • Role of extrinsic factors in cancer initiation: importance of the stressed niche in pancreatic cancer - Julie GUILLERMET-GUIBERT, Cancer Research Center of Toulouse (CRCT)
    • Metabolic and immune features as predictive biomarkers of risk stratification of skin carcinoma - Hamid-Reza REZVANI, BMGIC (Bordeaux)
    • 2 selected communications

 

14:15 - 15:50 : Parallel sessions organized by Cancéropôle GSO Axes

  • Cell signaling and therapeutic targets / Axis 1 session
    Chair: Violaine MOREAU & Julie PANNEQUIN
    • KEYNOTE SPEAKER : David SANTAMARIA, Inserm U1218 Action (Bordeaux) - Novel mechanisms controlling KRAS oncogenic output: impact on tumour fitness and cancer vulnerabilities
    • Sortilin exhibits tumor suppressor-like activity by limiting EGFR function - Thomas NAVES, CAPTuR (Contrôle de l'Activation cellulaire, Progression Tumorale et Résistance thérapeutique), University of Limoges
    • 3 selected communications

 

  • Genome dynamics and cancer / Axis 2 session
    Chair: Gaëlle LEGUBE & Malik LUTZMANN
    • KEYNOTE SPEAKER (virtual): Jo MORRIS, Institute of Cancer and Genomis Sciences, University of Birmingham (United Kingdom) - Back-up pathways that support BRCA1 deficient cells
    • Mechanisms preventing toxic DNA repair at single-ended DNA double-strand breaks - Sébastien BRITTON, Institute of Pharmacology and Structural Biology (Toulouse)
    • 3 selected communications

 

  • Patients-partenaire-formateur-co-chercheur : des savoirs expérientiels légitimes ? / session Axe 4
    Modération: 
    • 1 ORATEUR INVITE: Arnaud HALLOY, Université de Nice - Savoirs expérientiels et partenariat patient : une alliance indispensable | Intervention à distance
    • Table-ronde et discussion avec Sabine DUTHEUIL, Dolores ALBARACCIN, Frédéric BOUHIER

 

16:45 - 18:15 : Plenary session and session Axe 4

  • Research in Melanoma
    Chair: 

    • KEYNOTE SPEAKER: Daniel PEEPER, The Netherlands Cancer Institute, Amsterdam (The Netherlands) - Rational concepts for tumor & immune cell therapy combinations
    • Combining TNF inhibitors to anti-PD-1 and anti-CTLA-4 for the treatment of advanced melanoma patients - Anne MONTFORTCancer Research Center of Toulouse (CRCT)
    • The Transcutaneous MicroVasculoscope : a real time observation of the tumoral microvasculature - Xavier ORLIK, ONERA, Toulouse
    • 1 selected communications

 

  • Le patient-partenaire en institution  
    Modération:
     
    • Béatrice JACQUES, Centre Emile Durkheim - Introduction et enjeux
    • Sabine DUTHEIL, patient partenaire Bordeaux et Hortense FRANCK, oncoradiothérapeute Bordeaux - Patiente Partenaire au SEIN d’une équipe d’oncologie : un dispositif innovant
    • Juliane LAMELOT-PELARD, Université de Nantes - Accompagnement des femmes diagnostiquées d'un premier cancer du sein par une patiente-partenaire: Quels bénéfices à moyen et long termes ? Une étude comparative
    • Johanne VASSELLIER, ARS Nouvelle Aquitaine - Une expérimentation innovante : le salariat de patient partenaire en cancérologie

 

Friday 19th November

08:30 - 10:15 : Parallel sessions organized by Cancéropôle GSO Axes

  • Poor prognosis Cancers: Glioblastoma / Brain tumors / Axis 3 session
    Chair: 

    • 1 KEYNOTE SPEAKER
    • 2 invited speakers
    • 2 selected communications

 

  • Extracellular matrix & cancer / Axis 5 session
    Chair:
    • 1 KEYNOTE SPEAKER
    • 2 invited speakers
    • 2 selected communications

 

  • Le patient formateur / session Axe 4
    Modération: 
    • Béatrice JACQUES, centre Emile Durkheim - Introduction et enjeux
    • Olivia GROSS, LEPS UR 3412, Université Sorbonne Paris Nord - L'expérience de Bobigny | Intervention à distance
    • Ligue contre le cancer 33, (informations à venir) 
    • Université des patients de Bordeaux (informations à venir)

 

11:00 - 12:30: Plenary session and session Axe 4

  • Poor prognosis Cancers: Pancreatic cancer
    Chair: 

    • KEYNOTE SPEAKERs: Núria MALATS & Francisco REAL, CNIO, Madrid (Spain) 
    • 2 invited speakers
    • 1 selected communication

 

  • Le patient co-chercheur / session Axe 4
    Modération: 
    • Béatrice JACQUES - Introduction et enjeux
    • Lise MOLIMARD et Nathalie CAPLET, SIRIC Brio - titre à venir
    • Julien BIAUDET, Cancéropôle CLARA - Oncostarter thématisé "expérience patient"
    • Pascal RAGOUET, Centre Emile Durkheim - titre à venir